August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Crispin Hiley: Stephanie Saw on Post-Osimertinib Decision Making in EGFR+ NSCLC
Mar 27, 2025, 13:04

Crispin Hiley: Stephanie Saw on Post-Osimertinib Decision Making in EGFR+ NSCLC

Crispin Hiley, UK Clinical Director for Lung Cancer at GenesisCare, shared a post on X:

“Slick discussion of complexity post Osimertinib decision making for patients with EGFR mutation positive NSCLC by Stephanie Saw – it’s a good problem to have in 2025.”

Crispin Hiley